Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients

N. Hizawa, H. Makita, Y. Nasuhara, M. Hasegawa, K. Nagai, Y. Ito, Tomoko Betsuyaku, S. Konno, M. Nishimura

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

It was previously reported that the gain-of-function -28 guanine allele of the promoter single nucleotide polymorphism (SNP; cytosine to guanine substitution of nucleotide -28 (-28C>G)) in the CC chemokine ligand 5 gene (CCL5) was associated with susceptibility to late-onset asthma in patients who developed asthma at age ≥40 yrs. The clinical diagnosis of chronic obstructive pulmonary disease (COPD) includes emphysema and small airway disease, and upregulation of CCL5 has been described in the airways of patients with COPD. It was hypothesised that CCL5 has a genetic impact upon the variable expression of emphysema in patients with COPD. Patients with COPD were studied (n=267). All of the patients underwent pulmonary high-resolution computed tomography (CT), and visual scoring (CT score) was performed to determine emphysema severity. Three SNPs of CCL5 were genotyped, including -403G>A, -28C>G and 375T>C. A significant difference was found in CT score according to CCL5 genotype; the -28G allele was inversely associated with CT score. When the analysis was confined to 180 patients with bronchial reversibility of <15%, even stronger evidence for this association was noted. Functional single nucleotide polymorphisms in the CC chemokine ligand 5 gene were associated with milder emphysema. Together with previous findings, the present study may identify the CC chemokine ligand 5 gene as part of a common pathway in the pathogenesis of late-onset asthma and chronic obstructive pulmonary disease with milder emphysema. Copyright

Original languageEnglish
Pages (from-to)372-378
Number of pages7
JournalEuropean Respiratory Journal
Volume32
Issue number2
DOIs
Publication statusPublished - 2008 Aug
Externally publishedYes

Fingerprint

CC Chemokines
Chronic Obstructive Pulmonary Disease
Single Nucleotide Polymorphism
Emphysema
Ligands
Phenotype
Genes
Tomography
Asthma
Alleles
Guanine Nucleotides
Cytosine
Guanine
Up-Regulation
Genotype
Lung

Keywords

  • Chronic obstructive pulmonary disease
  • Emphysema
  • Genetics
  • Late-onset asthma
  • Small airway disease

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Hizawa, N., Makita, H., Nasuhara, Y., Hasegawa, M., Nagai, K., Ito, Y., ... Nishimura, M. (2008). Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients. European Respiratory Journal, 32(2), 372-378. https://doi.org/10.1183/09031936.00115307

Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients. / Hizawa, N.; Makita, H.; Nasuhara, Y.; Hasegawa, M.; Nagai, K.; Ito, Y.; Betsuyaku, Tomoko; Konno, S.; Nishimura, M.

In: European Respiratory Journal, Vol. 32, No. 2, 08.2008, p. 372-378.

Research output: Contribution to journalArticle

Hizawa, N, Makita, H, Nasuhara, Y, Hasegawa, M, Nagai, K, Ito, Y, Betsuyaku, T, Konno, S & Nishimura, M 2008, 'Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients', European Respiratory Journal, vol. 32, no. 2, pp. 372-378. https://doi.org/10.1183/09031936.00115307
Hizawa, N. ; Makita, H. ; Nasuhara, Y. ; Hasegawa, M. ; Nagai, K. ; Ito, Y. ; Betsuyaku, Tomoko ; Konno, S. ; Nishimura, M. / Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients. In: European Respiratory Journal. 2008 ; Vol. 32, No. 2. pp. 372-378.
@article{d7a55425ab574e919ce8b3abe4d71b42,
title = "Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients",
abstract = "It was previously reported that the gain-of-function -28 guanine allele of the promoter single nucleotide polymorphism (SNP; cytosine to guanine substitution of nucleotide -28 (-28C>G)) in the CC chemokine ligand 5 gene (CCL5) was associated with susceptibility to late-onset asthma in patients who developed asthma at age ≥40 yrs. The clinical diagnosis of chronic obstructive pulmonary disease (COPD) includes emphysema and small airway disease, and upregulation of CCL5 has been described in the airways of patients with COPD. It was hypothesised that CCL5 has a genetic impact upon the variable expression of emphysema in patients with COPD. Patients with COPD were studied (n=267). All of the patients underwent pulmonary high-resolution computed tomography (CT), and visual scoring (CT score) was performed to determine emphysema severity. Three SNPs of CCL5 were genotyped, including -403G>A, -28C>G and 375T>C. A significant difference was found in CT score according to CCL5 genotype; the -28G allele was inversely associated with CT score. When the analysis was confined to 180 patients with bronchial reversibility of <15{\%}, even stronger evidence for this association was noted. Functional single nucleotide polymorphisms in the CC chemokine ligand 5 gene were associated with milder emphysema. Together with previous findings, the present study may identify the CC chemokine ligand 5 gene as part of a common pathway in the pathogenesis of late-onset asthma and chronic obstructive pulmonary disease with milder emphysema. Copyright",
keywords = "Chronic obstructive pulmonary disease, Emphysema, Genetics, Late-onset asthma, Small airway disease",
author = "N. Hizawa and H. Makita and Y. Nasuhara and M. Hasegawa and K. Nagai and Y. Ito and Tomoko Betsuyaku and S. Konno and M. Nishimura",
year = "2008",
month = "8",
doi = "10.1183/09031936.00115307",
language = "English",
volume = "32",
pages = "372--378",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "2",

}

TY - JOUR

T1 - Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients

AU - Hizawa, N.

AU - Makita, H.

AU - Nasuhara, Y.

AU - Hasegawa, M.

AU - Nagai, K.

AU - Ito, Y.

AU - Betsuyaku, Tomoko

AU - Konno, S.

AU - Nishimura, M.

PY - 2008/8

Y1 - 2008/8

N2 - It was previously reported that the gain-of-function -28 guanine allele of the promoter single nucleotide polymorphism (SNP; cytosine to guanine substitution of nucleotide -28 (-28C>G)) in the CC chemokine ligand 5 gene (CCL5) was associated with susceptibility to late-onset asthma in patients who developed asthma at age ≥40 yrs. The clinical diagnosis of chronic obstructive pulmonary disease (COPD) includes emphysema and small airway disease, and upregulation of CCL5 has been described in the airways of patients with COPD. It was hypothesised that CCL5 has a genetic impact upon the variable expression of emphysema in patients with COPD. Patients with COPD were studied (n=267). All of the patients underwent pulmonary high-resolution computed tomography (CT), and visual scoring (CT score) was performed to determine emphysema severity. Three SNPs of CCL5 were genotyped, including -403G>A, -28C>G and 375T>C. A significant difference was found in CT score according to CCL5 genotype; the -28G allele was inversely associated with CT score. When the analysis was confined to 180 patients with bronchial reversibility of <15%, even stronger evidence for this association was noted. Functional single nucleotide polymorphisms in the CC chemokine ligand 5 gene were associated with milder emphysema. Together with previous findings, the present study may identify the CC chemokine ligand 5 gene as part of a common pathway in the pathogenesis of late-onset asthma and chronic obstructive pulmonary disease with milder emphysema. Copyright

AB - It was previously reported that the gain-of-function -28 guanine allele of the promoter single nucleotide polymorphism (SNP; cytosine to guanine substitution of nucleotide -28 (-28C>G)) in the CC chemokine ligand 5 gene (CCL5) was associated with susceptibility to late-onset asthma in patients who developed asthma at age ≥40 yrs. The clinical diagnosis of chronic obstructive pulmonary disease (COPD) includes emphysema and small airway disease, and upregulation of CCL5 has been described in the airways of patients with COPD. It was hypothesised that CCL5 has a genetic impact upon the variable expression of emphysema in patients with COPD. Patients with COPD were studied (n=267). All of the patients underwent pulmonary high-resolution computed tomography (CT), and visual scoring (CT score) was performed to determine emphysema severity. Three SNPs of CCL5 were genotyped, including -403G>A, -28C>G and 375T>C. A significant difference was found in CT score according to CCL5 genotype; the -28G allele was inversely associated with CT score. When the analysis was confined to 180 patients with bronchial reversibility of <15%, even stronger evidence for this association was noted. Functional single nucleotide polymorphisms in the CC chemokine ligand 5 gene were associated with milder emphysema. Together with previous findings, the present study may identify the CC chemokine ligand 5 gene as part of a common pathway in the pathogenesis of late-onset asthma and chronic obstructive pulmonary disease with milder emphysema. Copyright

KW - Chronic obstructive pulmonary disease

KW - Emphysema

KW - Genetics

KW - Late-onset asthma

KW - Small airway disease

UR - http://www.scopus.com/inward/record.url?scp=56149118121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56149118121&partnerID=8YFLogxK

U2 - 10.1183/09031936.00115307

DO - 10.1183/09031936.00115307

M3 - Article

C2 - 18385174

AN - SCOPUS:56149118121

VL - 32

SP - 372

EP - 378

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 2

ER -